Drug intelligence / Profile preview

Fe-Mesopone

Development stage: Preclinical
Modality: Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration: Intravenous (typical For Photodynamic Therapy Agents)

Overview

Fe-Mesopone is a synthetic porphyrin compound, specifically belonging to the class of organic compounds known as chlorins. These are large heterocyclic aromatic ring systems related to porphyrins. Fe-Mesopone has potential medical applications, particularly in photodynamic therapy for cancer treatment. In this context, it acts as a photosensitizer that can be activated by light to produce reactive oxygen species, leading to targeted destruction of cancer cells[1][3].

Beyond the preview

Go deeper on Fe-Mesopone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fe-Mesopone.

Explore the full profile